An interesting study published by the journal Clinicaland Developmental Immunology and the National Institute of Health has found that activation of the body’s cannabinoid receptors
After studying the effects of cannabinoid receptor activation on mice with high cholesterol, researchers found that; “CB2 activation decreased histological features, which were associated with erectile dysfunction in hypercholesterolemic mice.”
According to the study’s lead researcher, these results have important implications that could lead to cannabinoids and cannabis being used to treat erectile dysfunction, which effects over 30 million Americans.
The study – which can be found by clicking here – is one of the first of its kind.
